Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23800691)

1.

Multiple endocrine neoplasia syndromes associated with mutation of p27.

Lee M, Pellegata NS.

J Endocrinol Invest. 2013 Oct;36(9):781-7. doi: 10.3275/9021. Epub 2013 Jun 26. Review.

PMID:
23800691
2.

MENX and MEN4.

Pellegata NS.

Clinics (Sao Paulo). 2012;67 Suppl 1:13-8. Review.

3.

MENX.

Pellegata NS.

Ann Endocrinol (Paris). 2012 Apr;73(2):65-70. doi: 10.1016/j.ando.2012.04.001. Epub 2012 Apr 25. Review.

PMID:
22542001
4.

The MENX syndrome and p27: relationships with multiple endocrine neoplasia.

Molatore S, Pellegata NS.

Prog Brain Res. 2010;182:295-320. doi: 10.1016/S0079-6123(10)82013-8.

PMID:
20541671
5.

Multiple endocrine neoplasia type 4.

Lee M, Pellegata NS.

Front Horm Res. 2013;41:63-78. doi: 10.1159/000345670. Epub 2013 Mar 19. Review.

PMID:
23652671
6.

p27kip1: a new multiple endocrine neoplasia gene?

Marinoni I, Pellegata NS.

Neuroendocrinology. 2011;93(1):19-28. doi: 10.1159/000320366. Epub 2010 Oct 27. Review.

7.

A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.

Tonelli F, Giudici F, Giusti F, Marini F, Cianferotti L, Nesi G, Brandi ML.

Eur J Endocrinol. 2014 Aug;171(2):K7-K17. doi: 10.1530/EJE-14-0080. Epub 2014 May 12.

8.

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.

Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, Fend F, Graw J, Atkinson MJ.

Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15558-63. Epub 2006 Oct 9. Erratum in: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19213.

9.

Multiple endocrine neoplasia, the old and the new: a mini review.

Pasquali D, Di Matteo FM, Renzullo A, Accardo G, Esposito D, Barbato F, Colantuoni V, Circelli L, Conzo G.

G Chir. 2012 Nov-Dec;33(11-12):370-3. Review.

PMID:
23140918
10.

The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.

Ozawa A, Agarwal SK, Mateo CM, Burns AL, Rice TS, Kennedy PA, Quigley CM, Simonds WF, Weinstein LS, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ.

J Clin Endocrinol Metab. 2007 May;92(5):1948-51. Epub 2007 Feb 13.

PMID:
17299066
11.

A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.

Molatore S, Marinoni I, Lee M, Pulz E, Ambrosio MR, degli Uberti EC, Zatelli MC, Pellegata NS.

Hum Mutat. 2010 Nov;31(11):E1825-35. doi: 10.1002/humu.21354.

12.

Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Thakker RV.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-15. doi: 10.1016/j.mce.2013.08.002. Epub 2013 Aug 8. Review.

13.

p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.

Sekiya T, Bronstein MD, Benfini K, Longuini VC, Jallad RS, Machado MC, Goncalves TD, Osaki LH, Higashi L, Viana-Jr J, Kater C, Lee M, Molatore S, Francisco G, Chammas R, Naslavsky MS, Schlesinger D, Gama P, Duarte YA, Lebrão ML, Zatz M, Meirelles O, Liberman B, Fragoso MC, Toledo SP, Pellegata NS, Toledo RA.

Endocr Relat Cancer. 2014 Apr 28;21(3):395-404. doi: 10.1530/ERC-13-0486. Print 2014 Jun.

14.

Animal models of multiple endocrine neoplasia.

Wiedemann T, Pellegata NS.

Mol Cell Endocrinol. 2015 Jul 13. pii: S0303-7207(15)30013-7. doi: 10.1016/j.mce.2015.07.004. [Epub ahead of print]

PMID:
26184857
15.

Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors.

Molatore S, Kiermaier E, Jung CB, Lee M, Pulz E, Höfler H, Atkinson MJ, Pellegata NS.

Mol Cancer. 2010 May 21;9:116. doi: 10.1186/1476-4598-9-116.

16.

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.

Igreja S, Chahal HS, Akker SA, Gueorguiev M, Popovic V, Damjanovic S, Burman P, Wass JA, Quinton R, Grossman AB, Korbonits M.

Clin Endocrinol (Oxf). 2009 Feb;70(2):259-64. doi: 10.1111/j.1365-2265.2008.03379.x. Epub 2008 Aug 15.

PMID:
18710468
17.

Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.

Malanga D, De Gisi S, Riccardi M, Scrima M, De Marco C, Robledo M, Viglietto G.

Eur J Endocrinol. 2012 Mar;166(3):551-60. doi: 10.1530/EJE-11-0929. Epub 2011 Nov 30.

18.

Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.

Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gündogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA.

J Clin Endocrinol Metab. 2007 Aug;92(8):3321-5. Epub 2007 May 22.

PMID:
17519308
19.

MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.

Georgitsi M.

Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):425-37. doi: 10.1016/j.beem.2010.01.001. Review.

PMID:
20833334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk